Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study

L. Slovak, Marilyn; J. Kopecky, Kenneth; A. Cassileth, Peter; H. Harrington, David; S. Theil, Karl; N. Mohamed, Anwar; Paietta, Elizabeth; L. Willman, Cheryl; R. Head, David; M. Rowe, Jacob; J. Forman, Stephen; R. Appelbaum, Frederick

doi:10.1182/blood.v96.13.4075

Public

Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study

Shared by NobleBlocks on Dec 15, 2000 • 12:00 AM UTC

Authors:

Marilyn L. Slovak

Kenneth J. Kopecky

Peter A. Cassileth

Abstract

The associations of cytogenetics with complete remission (CR) rates, overall survival (OS), and outcomes after CR were studied in 609 previously untreated AML patients younger than 56 years old in a clinical trial comparing 3 intensive postremission therapies: intensive chemotherapy, autologous tran...

Subject

Internal medicine

Medicine

Cytogenetics

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!